Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

Clinical trial NCT00882557 · COMPLETED

Trial details

NCT number: NCT00882557
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End-stage Renal Disease Renal Failure Chronic Requiring Hemodialysis

Start date: 2009-04-29
Primary completion: 2009-07-17
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.